Morepen Laboratories Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Morepen Laboratories Limited generated cash of $733,746,000, which is more than the previous year. Cash used in financing activities reached the amount of $52,049,000 last year. Net change in cash is therefore -$47,207,000.
Cash Flow
| 2010 | 66.68M | -44.30M | -57.23M |
|---|---|---|---|
| 2011 | 89.76M | -35.38M | -39.59M |
| 2012 | 271.1M | -33.5M | -218.3M |
| 2016 | 500.71M | -272.99M | -272.58M |
| 2018 | 634.14M | -269.28M | -377.73M |
| 2020 | 110.17M | -124.61M | 54.88M |
| 2021 | 508.25M | -703.50M | 472.72M |
| 2023 | -911.70M | -465.09M | 1.43B |
| 2024 | 733.74M | -833.00M | 52.04M |
MOREPENLAB.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 216.65M | 158.02M | 136.39M | 95.95M | 70.04M | 88.48M | 25.8M | 11.02M | 45.87M |
Operating activities | |||||||||
Net income | 961.59M | 557.55M | 985.11M | 391.07M | 298.59M | 170.64M | -236.5M | -469.44M | -62.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 334.69M | 279.30M | 302.83M | 369.06M | 343.22M | 351.95M | 480.6M | 481.55M | 480.20M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -616.91M | -126.03M | -443.03M | -39.33M | -288.99M | -318.01M | 0 | 0 | 0 |
Inventories | -197.07M | 469.67M | -368.5M | -442.74M | -122.22M | -50.28M | -39.6M | -30.23M | -93.90M |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 733.74M | -911.70M | 508.25M | 110.17M | 634.14M | 500.71M | 271.1M | 89.76M | 66.68M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -5.37M | -299.57M | -10.62M | -2.17M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -713.80M | -459.72M | -403.98M | -170.67M | -268.82M | -99.38M | -32.1M | -35.87M | -44.46M |
Acquisitions Net | 0 | 0 | 50K | -46.05M | 158K | 5.21M | 0 | 0 | 0 |
Cash generated by investing activities | -833.00M | -465.09M | -703.50M | -124.61M | -269.28M | -272.99M | -33.5M | -35.38M | -44.30M |
Financing activities | |||||||||
Common Stock Issued | 0 | 1.37B | 437.5M | 0 | 0 | 0 | 0 | 0 | 1.04B |
Payments for dividends | 0 | 0 | 0 | -4.89M | -4.87M | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -35.77M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 38.35M | 65.95M | -35.77M | 15.24M | -344.29M | -188.56M | 0 | 0 | 0 |
Cash used in financing activities | 52.04M | 1.43B | 472.72M | 54.88M | -377.73M | -272.58M | -218.3M | -39.59M | -57.23M |
Net Change In Cash | -47.20M | 58.63M | 277.47M | 40.44M | -12.88M | -44.87M | 19.3M | 14.78M | -34.84M |
Cash at end of period | 169.45M | 216.65M | 413.86M | 136.39M | 57.16M | 43.61M | 45.1M | 25.81M | 11.02M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |